pmc logo image
Logo of jaccidemJournal URL: http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=155&action=archive
Journal List > J Accid Emerg Med > v.12(2); Jun 1995

Formats:
J Accid Emerg Med. 1995 June; 12(2): 89–100.
PMCID: PMC1342543
Copyright notice
Anaphylactic shock: mechanisms and treatment.
A F Brown
Department of Emergency Medicine, Royal Brisbane Hospital, Queensland, Australia.
Small right arrow pointing to: See letter "Anaphylactic shock." in volume 13 on page 150b.
 
Small right arrow pointing to: This article has been cited by other articles in PMC.
Abstract
This paper reviews the mechanisms of anaphylactic shock in terms of the immunoglobulin and non-immunoglobulin triggering events, and the cellular events based on the rise in intracellular cyclic AMP and calcium that release preformed granule-associated mediators and the rapidly formed, newly synthesized mediators predominantly based on arachidonic acid metabolism. These primary mediators recruit other cells with the release of secondary mediators that either potentiate or ultimately curtail the anaphylactic reaction. The roles of these mediators in the various causes of cardiovascular collapse are examined. The treatment of anaphylactic shock involves oxygen, adrenaline and fluids. The importance and safety of intravenous adrenaline are discussed. Combined H1 and H2 blocking antihistamines and steroids have a limited role. Glucagon and other adrenergic drugs are occasionally used, and several new experimental drugs are being developed.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.5M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
 
icon of scanned page 89
89
icon of scanned page 90
90
icon of scanned page 91
91
icon of scanned page 92
92
icon of scanned page 93
93
icon of scanned page 94
94
icon of scanned page 95
95
icon of scanned page 96
96
icon of scanned page 97
97
icon of scanned page 98
98
icon of scanned page 99
99
icon of scanned page 100
100
 
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Fisher M. Anaphylaxis. Dis Mon. 1987 Aug;33(8):433–479. [PubMed]
  • Samter M. Allergy and immunology 1947-1987. A PGM retrospective. Postgrad Med. 1987 Oct;82(5):147–150. [PubMed]
  • Fisher M. Treating anaphylaxis with sympathomimetic drugs. BMJ. 1992 Nov 7;305(6862):1107–1108. [PubMed]
  • Søreide E, Buxrud T, Harboe S. Severe anaphylactic reactions outside hospital: etiology, symptoms and treatment. Acta Anaesthesiol Scand. 1988 May;32(4):339–342. [PubMed]
  • Soto-Aguilar MC, deShazo RD, Waring NP. Anaphylaxis. Why it happens and what to do about it. Postgrad Med. 1987 Oct;82(5):154-60–162-4,167-70. [PubMed]
  • Holmes JL. Management of acute anaphylaxis. Aust Fam Physician. 1991 Sep;20(9):1267-9–1272-3. [PubMed]
  • Hodgson CA, Andersen BD. Latex allergy: an unfamiliar cause of intra-operative cardiovascular collapse. Anaesthesia. 1994 Jun;49(6):507–508. [PubMed]
  • Hirshman CA. Latex anaphylaxis. Anesthesiology. 1992 Aug;77(2):223–225. [PubMed]
  • Atkinson TP, Kaliner MA. Anaphylaxis. Med Clin North Am. 1992 Jul;76(4):841–855. [PubMed]
  • Huston DP, Bressler RB. Urticaria and angioedema. Med Clin North Am. 1992 Jul;76(4):805–840. [PubMed]
  • Corren J, Schocket AL. Anaphylaxis. A preventable emergency. Postgrad Med. 1990 Apr;87(5):167-8–171-8. [PubMed]
  • Stafford CT. Life-threatening allergic reactions. Anticipating and preparing are the best defenses. Postgrad Med. 1989 Jul;86(1):235-42–245. [PubMed]
  • Nichols AW. Exercise-induced anaphylaxis and urticaria. Clin Sports Med. 1992 Apr;11(2):303–312. [PubMed]
  • Briner WW., Jr Physical allergies and exercise. Clinical implications for those engaged in sports activities. Sports Med. 1993 Jun;15(6):365–373. [PubMed]
  • Wong S, Dykewicz MS, Patterson R. Idiopathic anaphylaxis. A clinical summary of 175 patients. Arch Intern Med. 1990 Jun;150(6):1323–1328. [PubMed]
  • Patterson R, Stoloff RS, Greenberger PA, Grammer LC, Harris KE. Algorithms for the diagnosis and management of idiopathic anaphylaxis. Ann Allergy. 1993 Jul;71(1):40–44. [PubMed]
  • Fisher MM, Baldo BA. Acute anaphylactic reactions. Med J Aust. 1988 Jul 4;149(1):34–38. [PubMed]
  • Yunginger JW. Anaphylaxis. Curr Probl Pediatr. 1992 Mar;22(3):130–147. [PubMed]
  • Borish L, Joseph BZ. Inflammation and the allergic response. Med Clin North Am. 1992 Jul;76(4):765–787. [PubMed]
  • Serafin WE, Austen KF. Mediators of immediate hypersensitivity reactions. N Engl J Med. 1987 Jul 2;317(1):30–34. [PubMed]
  • Sim TC. Anaphylaxis. How to manage and prevent this medical emergency. Postgrad Med. 1992 Oct;92(5):277-84–289,292-6. [PubMed]
  • Valentine MD, Lichtenstein LM. Anaphylaxis and stinging insect hypersensitivity. JAMA. 1987 Nov 27;258(20):2881–2885. [PubMed]
  • Monroe EW. Treatment of urticaria. Dermatol Clin. 1985 Jan;3(1):51–55. [PubMed]
  • Perkin RM, Anas NG. Mechanisms and management of anaphylactic shock not responding to traditional therapy. Ann Allergy. 1985 Mar;54(3):202–208. [PubMed]
  • Fisher MM. Clinical observations on the pathophysiology and treatment of anaphylactic cardiovascular collapse. Anaesth Intensive Care. 1986 Feb;14(1):17–21. [PubMed]
  • van der Linden PW, Struyvenberg A, Kraaijenhagen RJ, Hack CE, van der Zwan JK. Anaphylactic shock after insect-sting challenge in 138 persons with a previous insect-sting reaction. Ann Intern Med. 1993 Feb 1;118(3):161–168. [PubMed]
  • Nicolas F, Villers D, Blanloeil Y. Hemodynamic pattern in anaphylactic shock with cardiac arrest. Crit Care Med. 1984 Feb;12(2):144–145. [PubMed]
  • Criep LH, Woehler TR. The heart in human anaphylaxis. Ann Allergy. 1971 Aug;29(8):399–409. [PubMed]
  • Carlson RW, Bowles AL, Haupt MT. Anaphylactic, anaphylactoid, and related forms of shock. Crit Care Clin. 1986 Apr;2(2):347–372. [PubMed]
  • Schneiderman H, Hammerschmidt DE, McCall AR, Jacob HS. Fatal complement-induced leukostasis after diatrizoate injection. Principles of clinicopathologic diagnosis. JAMA. 1983 Nov 4;250(17):2340–2342. [PubMed]
  • Perkin RM, Anas NG. Pulmonary hypertension in pediatric patients. J Pediatr. 1984 Oct;105(4):511–522. [PubMed]
  • Wasserman SI. The heart in anaphylaxis. J Allergy Clin Immunol. 1986 May;77(5):663–666. [PubMed]
  • Raper RF, Fisher MM. Profound reversible myocardial depression after anaphylaxis. Lancet. 1988 Feb 20;1(8582):386–388. [PubMed]
  • Felix SB, Baumann G, Niemczyk M, Hashemi T, Ochsenfeld G, Ahmad Z, Shirani S, Blömer H. Effects of histamine H1- and H2-receptor antagonists on cardiovascular function during systemic anaphylaxis in guinea pigs. Agents Actions. 1991 Mar;32(3-4):245–252. [PubMed]
  • Moscati RM, Moore GP. Comparison of cimetidine and diphenhydramine in the treatment of acute urticaria. Ann Emerg Med. 1990 Jan;19(1):12–15. [PubMed]
  • Yarbrough JA, Moffitt JE, Brown DA, Stafford CT. Cimetidine in the treatment of refractory anaphylaxis. Ann Allergy. 1989 Sep;63(3):235–238. [PubMed]
  • Fisher MM, More DG. The epidemiology and clinical features of anaphylactic reactions in anaesthesia. Anaesth Intensive Care. 1981 Aug;9(3):226–234. [PubMed]
  • Netzel MC. Anaphylaxis: clinical presentation, immunologic mechanisms, and treatment. J Emerg Med. 1986;4(3):227–236. [PubMed]
  • Stoloff R, Adams SL, Orfan N, Harris KE, Greenberger PA, Patterson R. Emergency medical recognition and management of idiopathic anaphylaxis. J Emerg Med. 1992 Nov–Dec;10(6):693–698. [PubMed]
  • Lip GY, Metcalfe MJ. Adrenaline in allergic emergencies. BMJ. 1992 May 30;304(6839):1443. [PubMed]
  • Sullivan TJ. Cardiac disorders in penicillin-induced anaphylaxis. Association with intravenous epinephrine therapy. JAMA. 1982 Nov 5;248(17):2161–2162. [PubMed]
  • Roberts-Thomson P, Heddle R, Kupa A. Adrenaline and anaphylaxis. Med J Aust. 1985 Jun 24;142(13):708. [PubMed]
  • Fisher MM, Dicks I. Volume replacement in acute anaphylactoid reactions. Anaesth Intensive Care. 1979 Nov;7(4):375–376. [PubMed]
  • vanSonnenberg E, Neff CC, Pfister RC. Life-threatening hypotensive reactions to contrast media administration: comparison of pharmacologic and fluid therapy. Radiology. 1987 Jan;162(1 Pt 1):15–19. [PubMed]
  • Waldhausen E, Keser G, Marquardt B. Der anaphylaktische Schock. Anaesthesist. 1987 Apr;36(4):150–158. [PubMed]
  • Lieberman P. The use of antihistamines in the prevention and treatment of anaphylaxis and anaphylactoid reactions. J Allergy Clin Immunol. 1990 Oct;86(4 Pt 2):684–686. [PubMed]
  • Plaut M. Histamine, H1 and H2 antihistamines, and immediate hypersensitivity reactions. J Allergy Clin Immunol. 1979 Jun;63(6):371–375. [PubMed]
  • Harvey RP, Wegs J, Schocket AL. A controlled trial of therapy in chronic urticaria. J Allergy Clin Immunol. 1981 Oct;68(4):262–266. [PubMed]
  • Runge JW, Martinez JC, Caravati EM, Williamson SG, Hartsell SC. Histamine antagonists in the treatment of acute allergic reactions. Ann Emerg Med. 1992 Mar;21(3):237–242. [PubMed]
  • Valentine MD. Anaphylaxis and stinging insect hypersensitivity. JAMA. 1992 Nov 25;268(20):2830–2833. [PubMed]
  • Kambam JR, Merrill WH, Smith BE. Histamine 2 receptor blocker in the treatment of protamine related anaphylactoid reactions: two case reports. Can J Anaesth. 1989 Jul;36(4):463–465. [PubMed]
  • White MV, Igarashi Y, Lundgren JD, Shelhamer J, Kaliner M. Hydrocortisone inhibits rat basophilic leukemia cell mediator release induced by neutrophil-derived histamine releasing activity as well as by anti-IgE. J Immunol. 1991 Jul 15;147(2):667–673. [PubMed]
  • Toogood JH. Risk of anaphylaxis in patients receiving beta-blocker drugs. J Allergy Clin Immunol. 1988 Jan;81(1):1–5. [PubMed]
  • Lang DM, Alpern MB, Visintainer PF, Smith ST. Increased risk for anaphylactoid reaction from contrast media in patients on beta-adrenergic blockers or with asthma. Ann Intern Med. 1991 Aug 15;115(4):270–276. [PubMed]
  • Pollack CV., Jr Utility of glucagon in the emergency department. J Emerg Med. 1993 Mar–Apr;11(2):195–205. [PubMed]
  • Gullo A, Romano E. Naloxone and anaphylactic shock. Lancet. 1983 Apr 9;1(8328):819–819. [PubMed]
  • Muelleman RL, Pribble JP, Salomone JA., 3rd Blood pressure effects of thyrotropin-releasing hormone and epinephrine in anaphylactic shock. Ann Emerg Med. 1988 Apr;17(4):309–313. [PubMed]
  • Oertel T, Loehr MM. Bee-sting anaphylaxis: the use of medical antishock trousers. Ann Emerg Med. 1984 Jun;13(6):459–461. [PubMed]
  • Bickell WH, Dice WH. Military antishock trousers in a patient with adrenergic-resistant anaphylaxis. Ann Emerg Med. 1984 Mar;13(3):189–190. [PubMed]
  • Stark BJ, Sullivan TJ. Biphasic and protracted anaphylaxis. J Allergy Clin Immunol. 1986 Jul;78(1 Pt 1):76–83. [PubMed]
  • Arrang JM, Devaux B, Chodkiewicz JP, Schwartz JC. H3-receptors control histamine release in human brain. J Neurochem. 1988 Jul;51(1):105–108. [PubMed]
  • LaBella FS, Queen G, Glavin G, Durant G, Stein D, Brandes LJ. H3 receptor antagonist, thioperamide, inhibits adrenal steroidogenesis and histamine binding to adrenocortical microsomes and binds to cytochrome P450. Br J Pharmacol. 1992 Sep;107(1):161–164. [PubMed]
  • Clapham J, Kilpatrick GJ. Histamine H3 receptors modulate the release of [3H]-acetylcholine from slices of rat entorhinal cortex: evidence for the possible existence of H3 receptor subtypes. Br J Pharmacol. 1992 Dec;107(4):919–923. [PubMed]
  • Terashita Z, Takatani M, Nishikawa K. Pharmacological profile of TCV-309--a potent PAF antagonist. J Lipid Mediat. 1992 Jun–Jul;5(2):183–185. [PubMed]
  • Herbert JM, Lespy L, Maffrand JP. Protective effect of SR 27417, a novel PAF antagonist, on lethal anaphylactic and endotoxin-induced shock in mice. Eur J Pharmacol. 1991 Dec 3;205(3):271–276. [PubMed]
  • Szefler SJ. Anti-inflammatory drugs in the treatment of allergic disease. Med Clin North Am. 1992 Jul;76(4):953–975. [PubMed]
  • Bekemeier H, Hänsel F, Kuhn C. Oxygen free radical scavengers (OFRS) prevent vasodepression induced by anaphylaxis, dextran or u.v.-irradiation in mice and rats. Agents Actions. 1988 Feb;23(1-2):103–105. [PubMed]
  • Amir S, English AM. An inhibitor of nitric oxide production, NG-nitro-L-arginine-methyl ester, improves survival in anaphylactic shock. Eur J Pharmacol. 1991 Oct 2;203(1):125–127. [PubMed]
  • Shehadi WH, Toniolo G. Adverse reactions to contrast media: a report from the Committee on Safety of Contrast Media of the International Society of Radiology. Radiology. 1980 Nov;137(2):299–302. [PubMed]
  • Samter M, Beers RF., Jr Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann Intern Med. 1968 May;68(5):975–983. [PubMed]
  • Tanus T, Mines D, Atkins PC, Levinson AI. Serum tryptase in idiopathic anaphylaxis: a case report and review of the literature. Ann Emerg Med. 1994 Jul;24(1):104–107. [PubMed]
Articles from Journal of Accident & Emergency Medicine are provided here courtesy of
BMJ Group

PubMed articles by these authors